157 related articles for article (PubMed ID: 27682068)
1. A Randomized Study Evaluating Oral Fusidic Acid (CEM-102) in Combination With Oral Rifampin Compared With Standard-of-Care Antibiotics for Treatment of Prosthetic Joint Infections: A Newly Identified Drug-Drug Interaction.
Pushkin R; Iglesias-Ussel MD; Keedy K; MacLauchlin C; Mould DR; Berkowitz R; Kreuzer S; Darouiche R; Oldach D; Fernandes P
Clin Infect Dis; 2016 Dec; 63(12):1599-1604. PubMed ID: 27682068
[TBL] [Abstract][Full Text] [Related]
2. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid.
Aboltins CA; Page MA; Buising KL; Jenney AW; Daffy JR; Choong PF; Stanley PA
Clin Microbiol Infect; 2007 Jun; 13(6):586-91. PubMed ID: 17331125
[TBL] [Abstract][Full Text] [Related]
3. Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections.
Gilchrist SE; Lange D; Letchford K; Bach H; Fazli L; Burt HM
J Control Release; 2013 Aug; 170(1):64-73. PubMed ID: 23639451
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antibiotic resistance to orally administrable antibiotics in staphylococcal bone and joint infections in one of the largest university hospitals in Germany: is there a role for fusidic acid?
Klein S; Nurjadi D; Eigenbrod T; Bode KA
Int J Antimicrob Agents; 2016 Feb; 47(2):155-7. PubMed ID: 26774158
[TBL] [Abstract][Full Text] [Related]
5. Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy.
Peel TN; Buising KL; Dowsey MM; Aboltins CA; Daffy JR; Stanley PA; Choong PF
Antimicrob Agents Chemother; 2013 Jan; 57(1):350-5. PubMed ID: 23114758
[TBL] [Abstract][Full Text] [Related]
6. Community-acquired methicillin-resistant Staphylococcus aureus in bone and joint infections: development of rifampicin resistance.
Donaldson AD; Chan RC; Gosbell IB
Med J Aust; 2006 Feb; 184(4):196. PubMed ID: 16489910
[No Abstract] [Full Text] [Related]
7. Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections.
Knippenberg B; Page-Sharp M; Salman S; Clark B; Dyer J; Batty KT; Davis TM; Manning L
Antimicrob Agents Chemother; 2016 Aug; 60(8):4940-55. PubMed ID: 27270283
[TBL] [Abstract][Full Text] [Related]
8. Oral-Only Linezolid-Rifampin Is Highly Effective Compared with Other Antibiotics for Periprosthetic Joint Infection: Study of a Mouse Model.
Thompson JM; Saini V; Ashbaugh AG; Miller RJ; Ordonez AA; Ortines RV; Wang Y; Sterling RS; Jain SK; Miller LS
J Bone Joint Surg Am; 2017 Apr; 99(8):656-665. PubMed ID: 28419033
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.
Marsot A; Ménard A; Dupouey J; Muziotti C; Guilhaumou R; Blin O
Br J Clin Pharmacol; 2017 May; 83(5):1039-1047. PubMed ID: 27813241
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute post-surgical infection of joint arthroplasty.
Soriano A; García S; Bori G; Almela M; Gallart X; Macule F; Sierra J; Martínez JA; Suso S; Mensa J
Clin Microbiol Infect; 2006 Sep; 12(9):930-3. PubMed ID: 16882303
[TBL] [Abstract][Full Text] [Related]
11. Fusidic acid in bone and joint infections.
Atkins B; Gottlieb T
Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S79-93. PubMed ID: 10528790
[TBL] [Abstract][Full Text] [Related]
12. High-dose daptomycin together with rifampin as salvage therapy for prosthetic joint infections.
Herrera S; Sorlí L; Horcajada JP
Med Clin (Barc); 2017 Sep; 149(5):223-224. PubMed ID: 28602211
[No Abstract] [Full Text] [Related]
13. Rifampin combination therapy in staphylococcal prosthetic joint infections: a randomized controlled trial.
Karlsen ØE; Borgen P; Bragnes B; Figved W; Grøgaard B; Rydinge J; Sandberg L; Snorrason F; Wangen H; Witsøe E; Westberg M
J Orthop Surg Res; 2020 Aug; 15(1):365. PubMed ID: 32859235
[TBL] [Abstract][Full Text] [Related]
14. Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention.
Puhto AP; Puhto T; Niinimäki T; Ohtonen P; Leppilahti J; Syrjälä H
Int Orthop; 2015 Sep; 39(9):1785-91. PubMed ID: 26138772
[TBL] [Abstract][Full Text] [Related]
15. Clarithromycin, rifampicin and fusidic acid triple combination therapy for chronic folliculocentric pustulosis of the scalp.
Fremlin GA; Orpin S; Kaur MR
Clin Exp Dermatol; 2017 Dec; 42(8):913-914. PubMed ID: 28691163
[No Abstract] [Full Text] [Related]
16. Management of infections of osteoarticular prosthesis.
Barberán J
Clin Microbiol Infect; 2006 May; 12 Suppl 3():93-101. PubMed ID: 16669932
[TBL] [Abstract][Full Text] [Related]
17. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus.
Wang JL; Tang HJ; Hsieh PH; Chiu FY; Chen YH; Chang MC; Huang CT; Liu CP; Lau YJ; Hwang KP; Ko WC; Wang CT; Liu CY; Liu CL; Hsueh PR
Int J Antimicrob Agents; 2012 Aug; 40(2):103-7. PubMed ID: 22612900
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and safety of single, multiple, and loading doses of fusidic acid in healthy subjects.
Still JG; Clark K; Degenhardt TP; Scott D; Fernandes P; Gutierrez MJ
Clin Infect Dis; 2011 Jun; 52 Suppl 7():S504-12. PubMed ID: 21546627
[TBL] [Abstract][Full Text] [Related]
19. Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin.
Drancourt M; Stein A; Argenson JN; Roiron R; Groulier P; Raoult D
J Antimicrob Chemother; 1997 Feb; 39(2):235-40. PubMed ID: 9069545
[TBL] [Abstract][Full Text] [Related]
20. Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres.
Gilchrist SE; Rickard DL; Letchford K; Needham D; Burt HM
Mol Pharm; 2012 May; 9(5):1489-501. PubMed ID: 22482935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
